跳至主要内容
临床试验/NCT02935088
NCT02935088已完成不适用

Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures

Abbott Medical Devices71 个研究点 分布在 11 个国家目标入组 2,217 人开始时间: 2016年10月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,217
试验地点
71
主要终点
Number of Subjects With 12 Month Clinical Outcomes (MACE) Major Adverse Cardiac Events by FFR Values and Resting Indices

研究概览

简要总结

The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.

详细描述

The purpose of this study is to understand routine use of FFR and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.

The study will also collect data on the routine use of coronary physiologic measurements such as adenosine-induced hyperemia FFR, FFR by contrast-induced hyperemia,

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is presenting with STEMI, NSTEMI, unstable angina, or stable coronary artery disease
  • Patient is planned to have FFR performed or underwent a cardiac catheterization where FFR was performed for further PCI (Percutaneous Cardiac Intervention) consideration
  • Patient signs and dates written informed consent
  • Patient is eighteen years of age or older at the time of consent

排除标准

  • Patient has extremely tortuous or calcified coronary arteries
  • Patient with a patent coronary artery bypass graft to the target vessel

结局指标

主要结局

Number of Subjects With 12 Month Clinical Outcomes (MACE) Major Adverse Cardiac Events by FFR Values and Resting Indices

时间窗: 12 months

Major adverse cardiac events (MACE) is defined as a 12-month composite, including all cause death, documented non-fatal myocardial infarction, and unplanned hospitalization leading to urgent revascularization. Fisher Exact test will be performed to evaluate the association between 12-month MACE event and binary FFR variables respectively using the following FFR; Low FFR group (FFR ≤ 0.8) and high FFR group (FFR \> 0.8).

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (71)

Loading locations...

相似试验